Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
August 28, 2026
Not intended for U.S. and UK Media
Bayer submits application in Japan for expanded use of Kerendia in chronic kidney disease therapeutic area
August 24, 2026
Not intended for U.S. and UK Media
Bayer’s sevabertinib approved in Japan for patients with HER2-mutant non-small cell lung cancer
August 13, 2026
Not intended for U.S. and UK Media
Aflibercept 8 mg application for macular edema following retinal vein occlusion accepted for review in China
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
